Navigation Links
Bio-Artificial Pancreas Technology to Cure Diabetes Advances
Date:8/7/2013

WASHINGTON, Aug. 7, 2013 /PRNewswire-iReach/ -- The Squash Diabetes Campaign, launched by the Georgetown University Women's Squash Team* in December 2012 and sponsored by New Generation Foundation, today announced a $125,000 grant provided by the Chicago-based Chauncey and Marion D. McCormick Family Foundation. The grant will support efforts to launch human trials utilizing new breakthroughs in living-cell bio-artificial pancreas technology and pursue scalable sources of islet cells for transplant recipients.

"In addition to advancing this proven technology, this generous grant raises two important banners," said Tom Gibson, President of New Generation Foundation:

  • "It marks the beginning of our 'public' period, where Squash Diabetes will now be more visible in our advocacy and programmatic work -- beginning this September;
  • It also helps honor the life of the late Mrs. Charlotte McCormick, who had the gift of creative caring and was one of the first private philanthropists to provide major financial support to living-cell encapsulation technology -- to cure diabetes."

New Bio-Artificial "Encapsulife" Pancreas -- Points To A Cure for Diabetes

Successful animal trials in dogs and primates validate the great promise of automatically reversing diabetes, without use harmful immunosuppression drugs. A living-cell bio-artificial pancreas is comprised of encapsulated living islet cells, organized into a "patch." When the living-cell patch is implanted under the skin, it automatically produces insulin in response to glucose stimulation in the diabetic.

The most successful progress in this arena is based on NASA-derived technology discovered and advanced by physicist-astronaut Dr. Taylor Wang, Professor Emeritus of Vanderbilt University and more recently through Dr. Wang's collaboration with Dr. James Markmann, Chief of Transplant Surgery at Massachusetts General Hospital.

To Learn More:

About New Generation Foundation

New Generation Foundation works to raise awareness and funding to support a cure for diabetes and support other programs to promote access to opportunity for young people. New Generation Foundation, is a 501(c)(3) charitable organization based in Washington, D.C.

* http://hoyalink.georgetown.edu/organization/ABCS/news/details/20411?fromCampus=True

Media Contact: Thomas Gibson, New generation Foundation, 2023385314, tgibson@NewGenFoundation.org

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE New Generation Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. JDRF Announces Two Partnerships to Develop Stable, Pumpable Glucagon to Support Advanced Generation Artificial Pancreas Systems
2. Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas
3. Feasibility of Artificial Pancreas System Demonstrated in Real-World Setting
4. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
5. Cytos Biotechnology Ltd Reports Second Quarter 2013 Financial Results and Recent Developments
6. CAO Group Continues to Lead Innovation With launch of New, High Technology Turbo Forensic Light System
7. Medical Power Supply Market by Technology, Type & Application - Forecasts to 2017
8. University of Virginia Cancer Center Begins Using New Telemedicine Technology for Cervical Cancer Screenings
9. Kinex Receives Research Support from the Hong Kong Innovation and Technology Commission (ITC)
10. Bode Technology Reaches Sales Milestone of DNA Collectors
11. Frost & Sullivan Finds the Entrenched Nature of qPCR Technology Sustains the US Reagents Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... 12, 2016  Apellis Pharmaceuticals, Inc., today ... million Series D preferred stock financing, co-led ... Capital Group and venBio Global Strategic Fund, ... IB Investment, and Epidarex Capital. The proceeds of ... advance clinical trials in the Company,s ongoing ...
(Date:2/11/2016)... -- - Cardiac Marker Diagnostic Testing ... Cancer Therapy. - European Point of Care Diagnostic ... - Key Diagnostic Testing Markets. - Molecular Diagnostics ... Testing. - Molecular Diagnostics in Infectious Disease Testing. ... Products World Markets. - Point of Care Diagnostic ...
(Date:2/11/2016)... INC. (NasdaqCM: PDEX) today announced financial results for its fiscal ... filed its Quarterly Report on Form 10-Q for the second ... Commission today. --> --> ... --> Net sales for the three months ended ... million from $2.8 million for the three months ended December ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... Coco Libre, the maker of ... Carpet Events LA GRAMMY’s Style Lounge Event. Coco Libre will offer musicians and celebrities ... before the big event. The invitation-only gifting suite, held this year at the W ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... (WaaS), today announced the integration of Clarity Intelligence Platform (CIP) into Cielo®, a ... offer real-time business intelligence (BI) to their small and medium business (SMB) clients. ...
(Date:2/12/2016)... NC (PRWEB) , ... February 12, 2016 , ... AssureVest ... surrounding areas, is initiating a charity drive that will raise funds earmarked to purchase ... John C. Tayloe Elementary School. , “My school is in a low-income area and ...
(Date:2/12/2016)... ... , ... Erlanger Agency has announced a new partnership in its ongoing community ... on the fight against breast cancer, fundraising for a local woman named Carmen, who ... Carmen is a loving single mother of two boys who also serves as caregiver ...
(Date:2/12/2016)... ... February 12, 2016 , ... Miami Dental Specialists is excited to bring patients ... office. Beginning in January, Miami Dental Specialists will offer the non-metal implants as a ... office to be chosen by the dental implant manufacturer, Straumann, to bring this cutting-edge ...
Breaking Medicine News(10 mins):